HIV/AIDS Clinical Summary

Benefits of Growth Factors for HIV Infection

Treatment

Combination of 4 homeopathic growth factors (insulin-like growth factor-1, platelet-derived growth factor BB, transforming growth factor ß-1 and granulocyte-macrophage colony stimulating factors) administered orally, one tablet three times daily (morning, noon and night).

US Study on HIV Positive Adults – Peer Reviewed and Published

• 129 HIV infected people ages 26-62 years old
• Two and one-half years study with follow-up
• Seven U.S. cities

Proven Benefits and Statistically Significant Findings Compared to Placebo:

• Strengthened immune function, CD4, CD8 and CD45 cell count
• Reduced HIV viral load
• Strengthened metabolism
• Increased lean body mass
• Prevented hospitalizations and opportunistic infections
• Decreased inflammation
• No toxicity or adverse side effects
• Excellent patient compliance
• Proven long term treatment option

SA Study on HIV Positive children

• HIV–infected orphans and single parent children 1-12 years old
• Finetown settlement, Sr. Helen’s Sancta Maria School

Significant Findings

• Average of 6-7 cm height gain in 14 weeks of treatment thus supporting expected increased in lean mass
• Increased head circumference
• Increased appetite
• Increased strength and energy

Decreased occurrence in:

• Upper respiratory tract infections
• Throat infections
• Otitis media (ear infection)
• Skin irritation and lesions
• Sinusitis
• Lymphadenophy (lymph node swelling)
• Diarrhea
• Vomiting

Providing sustainable worldwide medical options to people and industry for a healthier future.

Read about the trip to South Africa.

Read about HIV/AIDS Fact in South Africa.

Read the HIV White Paper.

Read the HIV/AID Winning the Battle Press Release.